Ameer develops biomaterials and nanotechnology for regenerative engineering, tissue engineering, medical devices, drug delivery, and cell delivery applications.
Advance the biosciences
University Priority
Enhancing Quality of Life
Innovation in the biosciences is essential to helping us live longer and healthier lives.
Â鶹´«Ã½ scientists and researchers deliver cutting-edge treatments and cures through their pathbreaking work in synthetic biology, chemistry, cancer research, public health and more.
With collaboration across schools, campuses and partners such as Â鶹´«Ã½ Medicine, a significant percentage of the University’s research enterprise is dedicated to the biosciences. This page provides a snapshot of the transformative work taking place at Â鶹´«Ã½.
Â鶹´«Ã½ scientists have been blazing new trails in synthetic biology — an innovative marriage of engineering, physics and biological systems — for nearly two decades. Attracting world-class faculty and a growing NIH funding, CSB was established as a nexus of this emerging field that is poised to transform medicine, energy and more. With a recent $18.5 million grant from the U.S. Department of Energy, Â鶹´«Ã½ continues to lead in this space.
QSIB combines engineering, life sciences and medicine to create biocompatible electronics, photonics and microfluidics that merge seamlessly with the human body. QSIB's bioelectronic platforms attach to — or even integrate within — vital organs, unlocking unprecedented diagnostic, therapeutic and surgical possibilities. From advancing clinical care and biomedical research to enhancing athletic performance, fitness and overall wellness, QSIB’s innovations redefine what’s possible for human health and beyond.
Imagine therapies so precise they destroy cancer cells without harming healthy tissue, nanoscale materials that rebuild bone and restore spinal cord function, and “nanosponges” that cleanse oil spills and polluted water without endangering marine life. IIN is turning these possibilities into reality. From revolutionizing energy and the environment to redefining health care, this work in nanotechnology is opening doors to solutions once thought impossible.
One of the rigorously selected National Cancer Institute (NCI)-designated Comprehensive Cancer Centers, the Lurie Cancer Center has recently received NCI’s highest rating — overall “exceptional” — along with an estimated $30 million in core funding to build on its 50 years of breakthrough research leading to better ways of preventing, diagnosing and treating cancer.
Meet Some of Our Experts
Â鶹´«Ã½â€™s researchers make breakthroughs that advance healthcare for everyone.
With an emphasis on translational medicine, our physician-scientists and engineers are at the forefront of research and discovery.
McNally explores the genetics of cardiovascular and neuromuscular disorders and studies genetic mechanisms responsible for inherited diseases.
Gianneschi’s research sits at the cutting edge of biomaterials and nanotechnology, with a focus on engineering responsive, programmable materials for therapeutic and diagnostic applications.
Highlights
Learn about Â鶹´«Ã½â€™s leadership in the biosciences.
News
See Â鶹´«Ã½â€™s new developments in support of this priority.
By restructuring a common chemo drug, scientists boost its power by 10,000-fold
New study maps a core temperature sensor, exposing how it turns off and on
New system delivers CRISPR machinery more safely and effectively into cells
New study shows how bacteria juggle energy needs while digesting complex carbons
Scientists and engineers unlock the body’s healing powers.
The Denning Ataxia Center, part of the Feinberg Neuroscience Institute, will be dedicated to advancing the understanding, treatment and care for patients affected by ataxia.